| RS1565626928 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1565626951 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565626959 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565626988 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627023 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627040 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS1565627046 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627058 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627072 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS1565627084 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TUBA1A-related disorder, Lissencephaly due to TUBA1A mutation |
| RS1565627104 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627110 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiomyopathy, Cardiovascular phenotype |
| RS1565627116 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627145 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1565627164 |
TUBA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1565627184 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627190 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1565627220 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627253 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627260 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627304 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1565627324 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627339 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1565627364 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627390 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627513 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS1565627517 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627526 |
TUBA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1565627536 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1565627548 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627566 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565627615 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565627677 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627680 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627684 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627707 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Cerebellar vermis hypoplasia, Lissencephaly due to TUBA1A mutation |
| RS1565627712 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627727 |
TUBA1A
|
Health Risk |
Pathogenic |
Lissencephaly due to TUBA1A mutation, Tubulinopathy |
| RS1565627735 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627740 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1565627745 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS1565627777 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1565627795 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS1565627805 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Lissencephaly due to TUBA1A mutation |
| RS1565627873 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 10, Cardiovascular phenotype |
| RS1565628062 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565628078 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565628486 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565628520 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1565629479 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS1565629792 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS1565630293 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565631094 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS1565631381 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565631424 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565631428 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1565631430 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS1565631849 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565631856 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1565634591 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565635212 |
MEN1
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS1565635941 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565636541 |
AQP2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS1565637179 |
AQP2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS1565637189 |
AQP2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS1565637724 |
MEN1
|
Health Risk |
Pathogenic |
— |
| RS1565638316 |
PAK1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with macrocephaly, seizures |
| RS1565638431 |
SPI1
|
Health Risk |
Pathogenic |
PU.1-mutated agammaglobulinemia, Agammaglobulinemia 10 |
| RS1565640081 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565642121 |
ARID2
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 6, Coffin-Siris syndrome 6 |
| RS1565642765 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565644005 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1565644366 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1565645563 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565646772 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565647197 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565647767 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565647825 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1565648511 |
MEN1
|
Health Risk |
Pathogenic |
— |
| RS1565648547 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565648608 |
STAT2
|
Health Risk |
Pathogenic |
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection, Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection |
| RS1565648656 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565648789 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565649749 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS1565651223 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565651568 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565651820 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1565651873 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1565652689 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565652770 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1565653781 |
RDH5
|
Health Risk |
Likely pathogenic |
Pigmentary retinal dystrophy, Pigmentary retinal dystrophy |
| RS1565662161 |
KCNJ8
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Brugada syndrome |
| RS1565664095 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS1565666048 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1565666318 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1565669269 |
SOX5
|
Health Risk |
Likely pathogenic |
— |
| RS1565669640 |
SOX5
|
Health Risk |
Pathogenic/Likely pathogenic |
Lamb-Shaffer syndrome, Inborn genetic diseases |
| RS1565672299 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1565673352 |
PEX5
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS1565674604 |
COL2A1
|
Health Risk |
Pathogenic |
— |